Joshua T. Fox-Fuller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Joshua T. Fox-Fuller has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Clara Vila-Castelar
Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
2 shared publications - Edmarie Guzmán-Vélez
Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital , Boston, MA
2 shared publications - Francisco Lopera
Grupo de Neurociencias de Antioquia (GNA), Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia
2 shared publications - Molly K. Colvin
Massachusetts General Hospital
2 shared publications Patricia Espe-Pfeifer
Department of Psychiatry and Pediatrics, University of Iowa Health Care , Iowa City, IA
2 shared publicationsShawn K Acheson
Acheson Forensic NeuroPsyche Consulting , Waynesville, NC
2 shared publications
Latest Publications
- 9 September 2026
- Published by Oxford University Press (OUP) in Archives of Clinical Neuropsychology
- Vol. 41 (7)
The critical role for neuropsychologists in the assessment and diagnosis of learning disorders: a position paper from the National Academy of Neuropsychology position, education, and response committee
Objective: Learning disorders are common neurodevelopmental disorders that affect cognitive functioning across the lifespan and frequently co-occur with medical and psychiatric conditions. This updated position paper from National Academy of Neuropsychology (NAN)’s Position, Education, and Response Committee discusses the role of neuropsychologists in identifying and diagnosing learning disorders. Method: The history of learning disorders is reviewed, along with key legislation related to special education services and disability accommodations. Recent neuroscience, genetics, and education research related to learning disorders is integrated to outline current challenges and future goals for training, clinical practice, and advocacy. Results: Key recommendations for neuropsychologists related to the assessment of learning disorders are detailed, including routine screening, understanding the interface between neuropsychological evaluations and laws regulating access to special education services and disability accommodations, advocacy for insurance coverage, and training in assessment of learning disorders and appropriate interventions. The paper also highlights the incremental value of neuropsychological assessment in complex cases, including differential diagnosis, identification of co-occurring neurodevelopmental, psychiatric, and medical conditions, clarification of mechanisms underlying poor academic performance, and development of individualized intervention recommendations when school-based evaluation or response to intervention is insufficient. Conclusions: Clinical neuropsychologists are uniquely positioned to advance the science and assessment of learning disorders by integrating academic findings with developmental, cognitive, psychiatric, and medical information to clarify why a student is struggling and to guide individualized treatment planning. Such efforts have the potential to reduce disparities that confer increased risk for lifelong neuropsychological challenges.
- 9 September 2026
- Published by Oxford University Press (OUP) in Archives of Clinical Neuropsychology
- Vol. 41 (7)
The critical role for neuropsychologists in the assessment and diagnosis of learning disorders: a position paper from the National Academy of Neuropsychology position, education, and response committee
Objective: Learning disorders are common neurodevelopmental disorders that affect cognitive functioning across the lifespan and frequently co-occur with medical and psychiatric conditions. This updated position paper from National Academy of Neuropsychology (NAN)’s Position, Education, and Response Committee discusses the role of neuropsychologists in identifying and diagnosing learning disorders. Method: The history of learning disorders is reviewed, along with key legislation related to special education services and disability accommodations. Recent neuroscience, genetics, and education research related to learning disorders is integrated to outline current challenges and future goals for training, clinical practice, and advocacy. Results: Key recommendations for neuropsychologists related to the assessment of learning disorders are detailed, including routine screening, understanding the interface between neuropsychological evaluations and laws regulating access to special education services and disability accommodations, advocacy for insurance coverage, and training in assessment of learning disorders and appropriate interventions. The paper also highlights the incremental value of neuropsychological assessment in complex cases, including differential diagnosis, identification of co-occurring neurodevelopmental, psychiatric, and medical conditions, clarification of mechanisms underlying poor academic performance, and development of individualized intervention recommendations when school-based evaluation or response to intervention is insufficient. Conclusions: Clinical neuropsychologists are uniquely positioned to advance the science and assessment of learning disorders by integrating academic findings with developmental, cognitive, psychiatric, and medical information to clarify why a student is struggling and to guide individualized treatment planning. Such efforts have the potential to reduce disparities that confer increased risk for lifelong neuropsychological challenges.
- Open Access
- 1 November 2023
- Published by Cambridge University Press (CUP) in Journal of the International Neuropsychological Society
- Vol. 29 (s1) , 770-771
97 Looking in the Webcam Reflection: A Scoping Review of Videoconferencing-Based Teleneuropsychological Assessment Since the Start of the COVID-19 Pandemic
Objective:Following the start of the SARS-COV-2 (COVID-19) pandemic there was a rapid uptake in teleneuropsychology (TeleNP). Many clinicians and researchers used videoconferencing technologies (e.g., Zoom®) to conduct remote neuropsychological assessments. Prior reviews (e.g., Marra et al., 2020) have indicated promise for the use of videoconference-based approaches to cognitive assessment under certain circumstances, though arguably nobody foresaw the widespread use of teleNP during the pandemic. Given the rapid expansion in the teleNP literature in the past couple of years, in this scoping review we specifically discuss research updates made during the COVID-19 pandemic pertaining to teleNP assessment of adults conducted via videoconferencing and their potential clinical applications.Participants and Methods:GoogleScholar and PubMed were used to search for peer-reviewed original research articles published between January 1, 2020 (i.e., the approximate beginning of the COVID-19 pandemic) and August 1, 2022. Broad search terms were used pertaining to teleNP, remote cognitive assessment, videoconferencing, and neuropsychological assessment, resulting in 16 articles.Results:Though most of the included studies were based in the United States (n=5), there was international representation across studies (Chile=1; United Kingdom=1; Australia=2; New Zealand=1; France=2; Greece=1; Japan=2, Singapore=1). All of the identified articles examined TeleNP-related research questions using cognitive tests administered via videoconferencing that have been previously studied in-person to varying degrees. Several of the studies focused on psychometric characterization (i.e., reliability and validity) of the examined tests when delivered via videoconferencing, whereas others focused on demonstrating the relative equivalence of neuropsychological scores obtained via videoconferencing versus in-person evaluations.Conclusions:Formal psychometric studies of traditional in-person neuropsychological tests delivered via videoconferencing since the start of the COVID-19 pandemic suggest that this remote modality of assessment is generally reliable and valid. Moreover, multiple recent studies have demonstrated relative equivalence of neuropsychological scores obtained via videoconferencing versus neuropsychological test scores obtained in-person. When considered alongside teleNP research conducted prior to the COVID-19 pandemic (e.g. Cullum et al., 2014), recent studies on videoconference-based neuropsychological assessment indicate that videoconferencing may not necessarily be a complete substitute for an in-person comprehensive evaluation given the inherent limitations of the procedure. However, teleNP via videoconferencing may be a promising tool in the neuropsychologist’s toolbox because it can help reduce common barriers to in-person neuropsychological assessment (e.g., travel time to clinics). Additional research on videoconferencing-based cognitive assessment is needed, especially in low-and-middle income countries (LMIC) and diverse populations where there may be more economic barriers to remote neuropsychological assessment relative to more economically-developed countries. Notably it is possible that research from LMIC may have been missed through the screening processes used in this review (e.g., inclusion of articles written in English).
- 1 November 2023
- Published by Cambridge University Press (CUP) in Journal of the International Neuropsychological Society
- Vol. 29 (s1) , 770-771
Open Access97 Looking in the Webcam Reflection: A Scoping Review of Videoconferencing-Based Teleneuropsychological Assessment Since the Start of the COVID-19 Pandemic
Objective:Following the start of the SARS-COV-2 (COVID-19) pandemic there was a rapid uptake in teleneuropsychology (TeleNP). Many clinicians and researchers used videoconferencing technologies (e.g., Zoom®) to conduct remote neuropsychological assessments. Prior reviews (e.g., Marra et al., 2020) have indicated promise for the use of videoconference-based approaches to cognitive assessment under certain circumstances, though arguably nobody foresaw the widespread use of teleNP during the pandemic. Given the rapid expansion in the teleNP literature in the past couple of years, in this scoping review we specifically discuss research updates made during the COVID-19 pandemic pertaining to teleNP assessment of adults conducted via videoconferencing and their potential clinical applications.Participants and Methods:GoogleScholar and PubMed were used to search for peer-reviewed original research articles published between January 1, 2020 (i.e., the approximate beginning of the COVID-19 pandemic) and August 1, 2022. Broad search terms were used pertaining to teleNP, remote cognitive assessment, videoconferencing, and neuropsychological assessment, resulting in 16 articles.Results:Though most of the included studies were based in the United States (n=5), there was international representation across studies (Chile=1; United Kingdom=1; Australia=2; New Zealand=1; France=2; Greece=1; Japan=2, Singapore=1). All of the identified articles examined TeleNP-related research questions using cognitive tests administered via videoconferencing that have been previously studied in-person to varying degrees. Several of the studies focused on psychometric characterization (i.e., reliability and validity) of the examined tests when delivered via videoconferencing, whereas others focused on demonstrating the relative equivalence of neuropsychological scores obtained via videoconferencing versus in-person evaluations.Conclusions:Formal psychometric studies of traditional in-person neuropsychological tests delivered via videoconferencing since the start of the COVID-19 pandemic suggest that this remote modality of assessment is generally reliable and valid. Moreover, multiple recent studies have demonstrated relative equivalence of neuropsychological scores obtained via videoconferencing versus neuropsychological test scores obtained in-person. When considered alongside teleNP research conducted prior to the COVID-19 pandemic (e.g. Cullum et al., 2014), recent studies on videoconference-based neuropsychological assessment indicate that videoconferencing may not necessarily be a complete substitute for an in-person comprehensive evaluation given the inherent limitations of the procedure. However, teleNP via videoconferencing may be a promising tool in the neuropsychologist’s toolbox because it can help reduce common barriers to in-person neuropsychological assessment (e.g., travel time to clinics). Additional research on videoconferencing-based cognitive assessment is needed, especially in low-and-middle income countries (LMIC) and diverse populations where there may be more economic barriers to remote neuropsychological assessment relative to more economically-developed countries. Notably it is possible that research from LMIC may have been missed through the screening processes used in this review (e.g., inclusion of articles written in English).
- Open Access
- 1 November 2023
- Published by Cambridge University Press (CUP) in Journal of the International Neuropsychological Society
- Vol. 29 (s1) , 536-537
19 Oral Versus Written Trail Making Test Scores in Patients with Movement Disorders
Objective: During the COVID-19 pandemic the Oral Trail Making Test (O-TMT) was frequently used as a telehealth-compatible substitute for the written version of the Trail Making Test (W-TMT). There is significant debate among neuropsychologists about the degree to which the O-TMT measures the same cognitive abilities as the W-TMT (i.e., processing speed for part A and set-shifting for part B). Given the continued use of the O-TMT - especially for patients with fine-motor or visual impairments -we examined how O-TMT and W-TMT scores were correlated in patients with movement disorders.Participants and Methods: Between April 2021 and July 2022 thirty individuals with movement disorders (n=27 idiopathic Parkinson’s disease [PD]; n=1 drug-induced PD; n=1 progressive supranuclear palsy [PSP]; n=1 possible PSP) completed in-person neuropsychological evaluations at the Emory Brain Health Center in Atlanta, GA. The patients were on average 71.3 years old (SD=7.5 years), had 16 years of education (SD=2.8 years), and the majority were non-Hispanic White (n=27 White; n=3 African American) and male (n=17). In addition to other neuropsychological measures, these patients completed both the O-TMT and the W-TMT. O-TMT and W-TMT administration was counterbalanced across patients and took place thirty-minutes apart. Raw scores (i.e., time in seconds) to complete O-TMT and W-TMT part A and part B, as well as discrepancy scores (part B - part A), were used for statistical analysis; a raw score of 300 seconds was assigned when a participant could not complete that section of the O-TMT or W-TMT. Given the non-normal distribution of the data, Spearman correlations were performed between O-TMT and W-TMT scores.Results: Ten patients were unable to perform W-TMT part B. Of these, seven patients could also not perform O-TMT part B. Part A scores on O-TMT and W-TMT were not significantly correlated (rs = 0.27, p = .15). In contrast, part B scores were strongly correlated, such that slower performances on O-TMT part B corresponded with slower performances on W-TMT part B (rs = 0.82, p < .001). Discrepancy scores for the O-TMT and W-TMT were also significantly correlated, such that larger part A and part B discrepancy scores on O-TMT corresponded with larger discrepancy scores on W-TMT (rs = 0.78, p <.001). The pattern of results was replicated when examining these correlations only in patients who could complete all parts of O-TMT and W-TMT (n=19); part A scores of the O-TMT and W-TMT were again not correlated (rs = -0.20, p = .41), whereas the part B scores (rs = 0.54, p = .02) and discrepancy scores (rs = 0.59, p = .008) were significantly correlated.Conclusions: Results suggest that an oral version of the Trail Making Test shows promise as an alternative to the written version for assessing set shifting abilities. These findings are limited to patients with movement disorders, and future research with diverse patient populations could help determine whether O-TMT can be generalized to other patient groups. Additionally, future research should examine whether O-TMT scores obtained via virtual testing correspond with W-TMT scores obtained in-person.
- 1 November 2023
- Published by Cambridge University Press (CUP) in Journal of the International Neuropsychological Society
- Vol. 29 (s1) , 536-537
Open Access19 Oral Versus Written Trail Making Test Scores in Patients with Movement Disorders
Objective: During the COVID-19 pandemic the Oral Trail Making Test (O-TMT) was frequently used as a telehealth-compatible substitute for the written version of the Trail Making Test (W-TMT). There is significant debate among neuropsychologists about the degree to which the O-TMT measures the same cognitive abilities as the W-TMT (i.e., processing speed for part A and set-shifting for part B). Given the continued use of the O-TMT - especially for patients with fine-motor or visual impairments -we examined how O-TMT and W-TMT scores were correlated in patients with movement disorders.Participants and Methods: Between April 2021 and July 2022 thirty individuals with movement disorders (n=27 idiopathic Parkinson’s disease [PD]; n=1 drug-induced PD; n=1 progressive supranuclear palsy [PSP]; n=1 possible PSP) completed in-person neuropsychological evaluations at the Emory Brain Health Center in Atlanta, GA. The patients were on average 71.3 years old (SD=7.5 years), had 16 years of education (SD=2.8 years), and the majority were non-Hispanic White (n=27 White; n=3 African American) and male (n=17). In addition to other neuropsychological measures, these patients completed both the O-TMT and the W-TMT. O-TMT and W-TMT administration was counterbalanced across patients and took place thirty-minutes apart. Raw scores (i.e., time in seconds) to complete O-TMT and W-TMT part A and part B, as well as discrepancy scores (part B - part A), were used for statistical analysis; a raw score of 300 seconds was assigned when a participant could not complete that section of the O-TMT or W-TMT. Given the non-normal distribution of the data, Spearman correlations were performed between O-TMT and W-TMT scores.Results: Ten patients were unable to perform W-TMT part B. Of these, seven patients could also not perform O-TMT part B. Part A scores on O-TMT and W-TMT were not significantly correlated (rs = 0.27, p = .15). In contrast, part B scores were strongly correlated, such that slower performances on O-TMT part B corresponded with slower performances on W-TMT part B (rs = 0.82, p < .001). Discrepancy scores for the O-TMT and W-TMT were also significantly correlated, such that larger part A and part B discrepancy scores on O-TMT corresponded with larger discrepancy scores on W-TMT (rs = 0.78, p <.001). The pattern of results was replicated when examining these correlations only in patients who could complete all parts of O-TMT and W-TMT (n=19); part A scores of the O-TMT and W-TMT were again not correlated (rs = -0.20, p = .41), whereas the part B scores (rs = 0.54, p = .02) and discrepancy scores (rs = 0.59, p = .008) were significantly correlated.Conclusions: Results suggest that an oral version of the Trail Making Test shows promise as an alternative to the written version for assessing set shifting abilities. These findings are limited to patients with movement disorders, and future research with diverse patient populations could help determine whether O-TMT can be generalized to other patient groups. Additionally, future research should examine whether O-TMT scores obtained via virtual testing correspond with W-TMT scores obtained in-person.
- 15 September 2023
- Published by Oxford University Press (OUP) in Archives of Clinical Neuropsychology
- Vol. 39 (2) , 227-248
Tele-Neuropsychology: From Science to Policy to Practice
Objective: The primary aim of this paper is to accelerate the number of randomized experimental studies of the reliability and validity in-home tele-neuropsychological testing (tele-np-t). Method: We conducted a critical review of the tele-neuropsychology literature. We discuss this research in the context of the United States’ public and private healthcare payer systems, including the Centers for Medicare & Medicaid Services (CMS) and Current Procedural Terminology (CPT) coding system’s telehealth lists, and existing disparities in healthcare access. Results: The number of tele-np publications has been stagnant since the onset of the COVID-19 pandemic. There are less published experimental studies of tele-neuropsychology (tele-np), and particularly in-home tele-np-t, than other tele-np publications. There is strong foundational evidence of the acceptability, feasibility, and reliability of tele-np-t, but relatively few studies of the reliability and validity of in-home tele-np-t using randomization methodology. Conclusions: More studies of the reliability and validity of in-home tele-np-t using randomization methodology are necessary to support inclusion of tele-np-t codes on the CMS and CPT telehealth lists, and subsequently, the integration and delivery of in-home tele-np-t services across providers and institutions. These actions are needed to maintain equitable reimbursement of in-home tele-np-t services and address the widespread disparities in healthcare access.
- 15 September 2023
- Published by Oxford University Press (OUP) in Archives of Clinical Neuropsychology
- Vol. 39 (2) , 227-248
Tele-Neuropsychology: From Science to Policy to Practice
Objective: The primary aim of this paper is to accelerate the number of randomized experimental studies of the reliability and validity in-home tele-neuropsychological testing (tele-np-t). Method: We conducted a critical review of the tele-neuropsychology literature. We discuss this research in the context of the United States’ public and private healthcare payer systems, including the Centers for Medicare & Medicaid Services (CMS) and Current Procedural Terminology (CPT) coding system’s telehealth lists, and existing disparities in healthcare access. Results: The number of tele-np publications has been stagnant since the onset of the COVID-19 pandemic. There are less published experimental studies of tele-neuropsychology (tele-np), and particularly in-home tele-np-t, than other tele-np publications. There is strong foundational evidence of the acceptability, feasibility, and reliability of tele-np-t, but relatively few studies of the reliability and validity of in-home tele-np-t using randomization methodology. Conclusions: More studies of the reliability and validity of in-home tele-np-t using randomization methodology are necessary to support inclusion of tele-np-t codes on the CMS and CPT telehealth lists, and subsequently, the integration and delivery of in-home tele-np-t services across providers and institutions. These actions are needed to maintain equitable reimbursement of in-home tele-np-t services and address the widespread disparities in healthcare access.
- Open Access
- 16 June 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S3)
Decreased functional integration in higher‐order association areas in individuals with autosomal‐dominant Alzheimer’s disease: Findings from the Colombia‐Boston (COLBOS) biomarker study
Background: The disruption of brain functional connections has been linked to cognitive impairment in Alzheimer’s disease. The functional architecture of the brain can be modeled using graph theory, which provides metrics to describe both local and global network properties. Autosomal dominant Alzheimer’s disease (ADAD) provides a unique opportunity to study brain changes in preclinical AD since carriers of ADAD mutations are destined to develop dementia at young age and have a well‐characterized disease trajectory. Here, we applied a graph theory approach to examine the functional network topology in Presenilin‐1 (PSEN1) E280A carriers and non‐carriers.Methods: A total of 43 cognitively‐unimpaired individuals (18 PSEN1 carriers, 25 non‐carriers; mean age = 36.6±5.2) from the Colombia‐Boston biomarker study were included. Participants underwent resting‐state fMRI in a 3T scanner, and a comprehensive multi‐domain neuropsychological battery. fMRI data were preprocessed using C‐PAC. Global functional connectivity (FC) was derived from the nodal strength of the Pearson correlation matrix between time‐series of 400 ROIs [Shaeffer‐2016] within 6 different functional networks [Yeo‐2011]. The strength of within‐ (z) and between‐network (h) functional integration was derived from a consensus modularity analysis [Dwyer‐2014]. Differences in cognitive variables were evaluated using Mann‐Whitney tests. Differences in FC were assessed using permutation methods: global FC using FSL‐randomize and integration parameters were based on a consensus analysis applied to random controlled matrices. Both methods were repeated 1000 times, with a p<0.05 significance threshold.Results: There were no group differences in cognitive variables. Compared to non‐carriers, carriers exhibited decreased local FC in higher‐order association areas, and increased connectivity in somatosensory areas. There were no group differences in the within‐network integration. Carriers showed decreased between‐network integration, especially in higher‐order association networks, mainly the default mode network (Fig.1).Conclusions: Findings support the hypothesis that alterations of functional network topology are evident in preclinical ADAD, primarily in the higher‐order cognitive networks. Early identification of abnormalities within these networks may be useful in understanding how FC changes may lead to subsequent cognitive decline in individuals at increased risk for AD. Future work with larger samples should investigate the relationships between FC changes and the neurobiological factors underlying AD.
- 16 June 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S3)
Open AccessDecreased functional integration in higher‐order association areas in individuals with autosomal‐dominant Alzheimer’s disease: Findings from the Colombia‐Boston (COLBOS) biomarker study
Background: The disruption of brain functional connections has been linked to cognitive impairment in Alzheimer’s disease. The functional architecture of the brain can be modeled using graph theory, which provides metrics to describe both local and global network properties. Autosomal dominant Alzheimer’s disease (ADAD) provides a unique opportunity to study brain changes in preclinical AD since carriers of ADAD mutations are destined to develop dementia at young age and have a well‐characterized disease trajectory. Here, we applied a graph theory approach to examine the functional network topology in Presenilin‐1 (PSEN1) E280A carriers and non‐carriers.Methods: A total of 43 cognitively‐unimpaired individuals (18 PSEN1 carriers, 25 non‐carriers; mean age = 36.6±5.2) from the Colombia‐Boston biomarker study were included. Participants underwent resting‐state fMRI in a 3T scanner, and a comprehensive multi‐domain neuropsychological battery. fMRI data were preprocessed using C‐PAC. Global functional connectivity (FC) was derived from the nodal strength of the Pearson correlation matrix between time‐series of 400 ROIs [Shaeffer‐2016] within 6 different functional networks [Yeo‐2011]. The strength of within‐ (z) and between‐network (h) functional integration was derived from a consensus modularity analysis [Dwyer‐2014]. Differences in cognitive variables were evaluated using Mann‐Whitney tests. Differences in FC were assessed using permutation methods: global FC using FSL‐randomize and integration parameters were based on a consensus analysis applied to random controlled matrices. Both methods were repeated 1000 times, with a p<0.05 significance threshold.Results: There were no group differences in cognitive variables. Compared to non‐carriers, carriers exhibited decreased local FC in higher‐order association areas, and increased connectivity in somatosensory areas. There were no group differences in the within‐network integration. Carriers showed decreased between‐network integration, especially in higher‐order association networks, mainly the default mode network (Fig.1).Conclusions: Findings support the hypothesis that alterations of functional network topology are evident in preclinical ADAD, primarily in the higher‐order cognitive networks. Early identification of abnormalities within these networks may be useful in understanding how FC changes may lead to subsequent cognitive decline in individuals at increased risk for AD. Future work with larger samples should investigate the relationships between FC changes and the neurobiological factors underlying AD.
- Open Access
- 24 January 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (2) , 199
Changes in Apathy, Depression, and Anxiety in Parkinson’s Disease from before to during the COVID-19 Era
Apathy, depression, and anxiety are common non-motor symptoms of Parkinson’s disease (PD). Tracking the changes in such symptoms over time would be valuable not only to determine their natural course during the disease, but also to establish the effects of unusual historical events interacting with the natural course. Having collected data on apathy (Apathy Scale), depression (Beck Depression Inventory-II), and anxiety (Parkinson’s Anxiety Scale) in a large sample of persons with PD (PwPD) before the beginning of the COVID-19 era, we followed up with these individuals to investigate the changes in their prevalence of apathy, depression, and anxiety across two timepoints (T1 and T2). Of the original 347 participants, 111 responded and provided complete data at T2. The data collection at T1, before COVID-19, occurred between 2017–2018. The data collection at T2 occurred in 2021 and included the same measures, with the addition of the Coronavirus Impact Scale to assess the effects of the pandemic on the individual participants. Over this period, there was a significant increase in apathy, but not in depression or anxiety. Anxiety and depression, but not apathy, were correlated with the impact of COVID-19.
- 24 January 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (2) , 199
Open AccessChanges in Apathy, Depression, and Anxiety in Parkinson’s Disease from before to during the COVID-19 Era
Apathy, depression, and anxiety are common non-motor symptoms of Parkinson’s disease (PD). Tracking the changes in such symptoms over time would be valuable not only to determine their natural course during the disease, but also to establish the effects of unusual historical events interacting with the natural course. Having collected data on apathy (Apathy Scale), depression (Beck Depression Inventory-II), and anxiety (Parkinson’s Anxiety Scale) in a large sample of persons with PD (PwPD) before the beginning of the COVID-19 era, we followed up with these individuals to investigate the changes in their prevalence of apathy, depression, and anxiety across two timepoints (T1 and T2). Of the original 347 participants, 111 responded and provided complete data at T2. The data collection at T1, before COVID-19, occurred between 2017–2018. The data collection at T2 occurred in 2021 and included the same measures, with the addition of the Coronavirus Impact Scale to assess the effects of the pandemic on the individual participants. Over this period, there was a significant increase in apathy, but not in depression or anxiety. Anxiety and depression, but not apathy, were correlated with the impact of COVID-19.
- Open Access
- 24 September 2021
- Published by Oxford University Press (OUP) in Archives of Clinical Neuropsychology
- Vol. 37 (2) , 274-291
Survey Findings About the Experiences, Challenges, and Practical Advice/Solutions Regarding Teleneuropsychological Assessment in Adults
In the wake of the coronavirus pandemic, teleneuropsychology utilization has increased. There is a need to characterize the first-hand experiences of individuals using teleneuropsychology, identify the common teleneuropsychology challenges, and devise practical strategies for mitigating/resolving these challenges. Survey data were collected from U.S. based neuropsychologists and other individuals (e.g., graduate students and research assistants) who were engaged in remote cognitive assessment with adults (n = 87). Frequency analyses were conducted to examine: how respondents used teleneuropsychology (e.g., duration of use, types of measures and devices/technology platforms used); challenges that were encountered with different technology platforms and teleneuropsychology use; and advice for navigating these challenges. Most respondents began using teleneuropsychology relatively recently in the context of the coronavirus pandemic, with home-to-home or clinic-to-home settings being the most frequently reported teleneuropsychology settings. Zoom®, Doxy.Me®, and MyChart® were the most frequently used platforms, largely due to workplace mandates and/or Health Insurance Portability and Accountability Act-compliant features. Common challenges with teleneuropsychology included internet connection issues and environmental distractions in examinees’ homes, and examinees having limited-to-no access to technologies requisite for teleneuropsychology. Providing clear instructions to the examinee prior to the teleneuropsychology visit was the most common advice for ensuring a successful teleneuropsychology evaluation. Similar response patterns were generally noted for those who used TeleNP for clinical or research purposes. These survey results reflect common experiences and challenges with teleneuropsychology and identify priority targets for increasing its feasibility, reliability, and validity. Findings provide context for the development of formal teleneuropsychology competencies.
- 24 September 2021
- Published by Oxford University Press (OUP) in Archives of Clinical Neuropsychology
- Vol. 37 (2) , 274-291
Open AccessSurvey Findings About the Experiences, Challenges, and Practical Advice/Solutions Regarding Teleneuropsychological Assessment in Adults
In the wake of the coronavirus pandemic, teleneuropsychology utilization has increased. There is a need to characterize the first-hand experiences of individuals using teleneuropsychology, identify the common teleneuropsychology challenges, and devise practical strategies for mitigating/resolving these challenges. Survey data were collected from U.S. based neuropsychologists and other individuals (e.g., graduate students and research assistants) who were engaged in remote cognitive assessment with adults (n = 87). Frequency analyses were conducted to examine: how respondents used teleneuropsychology (e.g., duration of use, types of measures and devices/technology platforms used); challenges that were encountered with different technology platforms and teleneuropsychology use; and advice for navigating these challenges. Most respondents began using teleneuropsychology relatively recently in the context of the coronavirus pandemic, with home-to-home or clinic-to-home settings being the most frequently reported teleneuropsychology settings. Zoom®, Doxy.Me®, and MyChart® were the most frequently used platforms, largely due to workplace mandates and/or Health Insurance Portability and Accountability Act-compliant features. Common challenges with teleneuropsychology included internet connection issues and environmental distractions in examinees’ homes, and examinees having limited-to-no access to technologies requisite for teleneuropsychology. Providing clear instructions to the examinee prior to the teleneuropsychology visit was the most common advice for ensuring a successful teleneuropsychology evaluation. Similar response patterns were generally noted for those who used TeleNP for clinical or research purposes. These survey results reflect common experiences and challenges with teleneuropsychology and identify priority targets for increasing its feasibility, reliability, and validity. Findings provide context for the development of formal teleneuropsychology competencies.
- Open Access
Amyloid-β and tau pathologies relate to distinctive brain dysconnectomics in preclinical autosomal dominant Alzheimer’s disease
The human brain is composed of functional networks that have a modular topology, where brain regions are organized into communities that form internally dense (segregated) and externally sparse (integrated) subnetworks that underlie higher-order cognitive functioning. It is hypothesized that amyloid-β and tau pathology in preclinical Alzheimer’s disease (AD) spread through functional networks, disrupting neural communication that results in cognitive dysfunction. We used high-resolution (voxel-level) graph-based network analyses to test whether in vivo amyloid-β and tau burden was associated with the segregation and integration of brain functional connections, and episodic memory, in cognitively-unimpaired Presenilin-1 E280A carriers who are expected to develop early-onset AD dementia in approximately 13 years on average. Compared to non-carriers, mutation carriers exhibited less functional segregation and integration in posterior default-mode network (DMN) regions, particularly the precuneus, and in the retrospenial cortex, which has been shown to link medial temporal regions and cortical regions of the DMN. Mutation carriers also showed greater functional segregation and integration in regions connected to the salience network, including the striatum and thalamus. Greater tau burden was associated with lower segregated and integrated functional connectivity of DMN regions, particularly the precuneus and medial prefrontal cortex. In turn, greater tau pathology was related to higher segregated and integrated functional connectivity in the retrospenial cortex, and the anterior cingulate cortex, a hub of the salience network. These findings enlighten our understanding of how AD-related pathology distinctly alters the brain’s functional architecture in the preclinical stage, possibly contributing to pathology propagation and ultimately resulting in dementia. SIGNIFICANCE STATEMENT: Amyloid-β and tau pathologies in Alzheimer’s disease (AD) are hypothesized to propagate through functional networks. Research is needed to elucidate how AD-related pathologies alter the brain’s functional connections years before symptom-onset to help predict pathology accumulation and dementia risk. Using high-resolution (voxel-level) graph-based network analyses and PET imaging, we showed that greater tau burden was associated with largely dysconnectivity of posterior default-mode network brain regions, and increased connectivity of structures associated with the salience network and others that are critical for integrating information across neural systems in cognitively-unimpaired Presenilin-1 E280A carriers. Findings enlighten how amyloid-β and tau relate to distinct patterns of functional connectivity in regions that underlie memory functioning and are critical for information processing, helping predict disease progression.
Open AccessAmyloid-β and tau pathologies relate to distinctive brain dysconnectomics in preclinical autosomal dominant Alzheimer’s disease
The human brain is composed of functional networks that have a modular topology, where brain regions are organized into communities that form internally dense (segregated) and externally sparse (integrated) subnetworks that underlie higher-order cognitive functioning. It is hypothesized that amyloid-β and tau pathology in preclinical Alzheimer’s disease (AD) spread through functional networks, disrupting neural communication that results in cognitive dysfunction. We used high-resolution (voxel-level) graph-based network analyses to test whether in vivo amyloid-β and tau burden was associated with the segregation and integration of brain functional connections, and episodic memory, in cognitively-unimpaired Presenilin-1 E280A carriers who are expected to develop early-onset AD dementia in approximately 13 years on average. Compared to non-carriers, mutation carriers exhibited less functional segregation and integration in posterior default-mode network (DMN) regions, particularly the precuneus, and in the retrospenial cortex, which has been shown to link medial temporal regions and cortical regions of the DMN. Mutation carriers also showed greater functional segregation and integration in regions connected to the salience network, including the striatum and thalamus. Greater tau burden was associated with lower segregated and integrated functional connectivity of DMN regions, particularly the precuneus and medial prefrontal cortex. In turn, greater tau pathology was related to higher segregated and integrated functional connectivity in the retrospenial cortex, and the anterior cingulate cortex, a hub of the salience network. These findings enlighten our understanding of how AD-related pathology distinctly alters the brain’s functional architecture in the preclinical stage, possibly contributing to pathology propagation and ultimately resulting in dementia. SIGNIFICANCE STATEMENT: Amyloid-β and tau pathologies in Alzheimer’s disease (AD) are hypothesized to propagate through functional networks. Research is needed to elucidate how AD-related pathologies alter the brain’s functional connections years before symptom-onset to help predict pathology accumulation and dementia risk. Using high-resolution (voxel-level) graph-based network analyses and PET imaging, we showed that greater tau burden was associated with largely dysconnectivity of posterior default-mode network brain regions, and increased connectivity of structures associated with the salience network and others that are critical for integrating information across neural systems in cognitively-unimpaired Presenilin-1 E280A carriers. Findings enlighten how amyloid-β and tau relate to distinct patterns of functional connectivity in regions that underlie memory functioning and are critical for information processing, helping predict disease progression.
- Open Access
- 16 April 2019
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences
- Vol. 75 (9) , 1894-1904
Hallucinations and Delusions Signal Alzheimer’s Associated Cognitive Dysfunction More Strongly Compared to Other Neuropsychiatric Symptoms
Neuropsychiatric symptoms (NPS) are common among individuals with dementia of the Alzheimer’s type (DAT). We sought to characterize which NPS more purely relate to cognitive dysfunction in DAT, relative to other NPS. Demographic, neurocognitive, neuroimaging, and NPS data were mined from the Alzheimer’s Disease Neuroimaging Initiative database (n = 906). Using factor analysis, we analyzed the degree to which individual NPS were associated with DAT-associated cognitive dysfunction. We also employed item response theory to graphically depict the ability of individual NPS to index DAT-associated cognitive dysfunction across a continuum ranging from cognitively normal to mild DAT. Psychotic symptoms (hallucinations and delusions) were more strongly related to the continuum of DAT-associated cognitive dysfunction than other NPS, with the strength of the relationship peaking at high levels of disease severity. Psychotic symptoms also negatively correlated with brain volume and did not relate to the presence of vision problems. Aberrant motor behavior and apathy had relatively smaller associations with DAT-associated cognitive dysfunction, while other NPS showed minimal associations. Psychotic symptoms most strongly indexed DAT-associated cognitive dysfunction, whereas other NPS, such as depression and anxiety, were not as precisely related to the DAT-associated cognitive dysfunction.
- 16 April 2019
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences
- Vol. 75 (9) , 1894-1904
Open AccessHallucinations and Delusions Signal Alzheimer’s Associated Cognitive Dysfunction More Strongly Compared to Other Neuropsychiatric Symptoms
Neuropsychiatric symptoms (NPS) are common among individuals with dementia of the Alzheimer’s type (DAT). We sought to characterize which NPS more purely relate to cognitive dysfunction in DAT, relative to other NPS. Demographic, neurocognitive, neuroimaging, and NPS data were mined from the Alzheimer’s Disease Neuroimaging Initiative database (n = 906). Using factor analysis, we analyzed the degree to which individual NPS were associated with DAT-associated cognitive dysfunction. We also employed item response theory to graphically depict the ability of individual NPS to index DAT-associated cognitive dysfunction across a continuum ranging from cognitively normal to mild DAT. Psychotic symptoms (hallucinations and delusions) were more strongly related to the continuum of DAT-associated cognitive dysfunction than other NPS, with the strength of the relationship peaking at high levels of disease severity. Psychotic symptoms also negatively correlated with brain volume and did not relate to the presence of vision problems. Aberrant motor behavior and apathy had relatively smaller associations with DAT-associated cognitive dysfunction, while other NPS showed minimal associations. Psychotic symptoms most strongly indexed DAT-associated cognitive dysfunction, whereas other NPS, such as depression and anxiety, were not as precisely related to the DAT-associated cognitive dysfunction.